Gilead

Achillion, Vertex rally on Gilead's woes
Marketwatch
Fri, 02/17/12 - 01:17 pm
Vertex
Gilead
Achillion
GS-7977
protease inhibitors
hepatitis C
Gilead Suffers First Hep C Drug Setback
TheStreet.com
Fri, 02/17/12 - 09:05 am
Gilead
hepatitis C
GS-7977
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
BIO CEO Conference
Pfizer
Indenix
Keryx
Delcath
Oncothyreon
Acorda Therapeutics
Human Genome Sciences
Gilead
Alexion Pharmaceuticals: A Tricky Mix Of Biotech And Pharma
Seeking Alpha
Tue, 02/14/12 - 11:19 am
Alexion
Gilead
Amgen
Soliris
Biogen Idec
Gilead: FDA Fast Tracks Review Of HIV Drug Truvada
Morningstar
Tue, 02/14/12 - 11:02 am
Truvada
fast track
FDA
Gilead
HIV
Gilead, Vertex and the Mystery of Missing Hep C Patients
TheStreet.com
Mon, 02/13/12 - 10:31 am
Vertex
hepatitis C
Gilead
There’s no Stopping Gilead Sciences
Motley Fool
Mon, 02/6/12 - 09:45 am
Gilead
Idenix Falls Casualty to Gilead Hep C Hoopla
TheStreet.com
Fri, 02/3/12 - 11:56 am
Gilead
hepatitis C
Idenix
Gilead Sciences 4Q profit rises on HIV drug sales
Yahoo/AP
Fri, 02/3/12 - 09:47 am
earnings
HIV
Gilead
Gilead Stock, In Top Group, Slips Before Earnings
Investors.com
Thu, 02/2/12 - 11:56 am
Gilead
earnings
Which Big Biotech Is the Best Bet?
Motley Fool
Tue, 01/31/12 - 08:01 am
Gilead
Amgen
Celgene
Biogen Idec
Gilead Sciences Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Mon, 01/30/12 - 03:51 pm
Gilead
earnings
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Seeking Alpha
Fri, 01/27/12 - 11:08 am
Alexion
Amgen
Ariad
Biogen Idec
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
Vertex Pharmaceuticals
Gilead not immune to concern over Truvada’s wider HIV use
FT.com
Tue, 01/24/12 - 11:22 am
HIV
Truvada
Gilead
3 Lessons From the J.P. Morgan Health-Care Confab
Motley Fool
Mon, 01/16/12 - 10:43 am
SOMA
Regeneron
Vertex
Gilead
GSK
Biocryst
Dendreon
InterMune
Analyzing 5 Biotech Stocks And Their Takeover Potential
Seeking Alpha
Fri, 01/13/12 - 10:33 am
Abbott Laboratories
Achillion
Alexion
Bristol-Myers Squibb
Gilead
GSK
Human Genome Sciences
Indenix
Inhibitex
JNJ
Pfizer
Vertex
Pharmasset
Gilead nears completion of Pharmasset deal
Yahoo/AP
Thu, 01/12/12 - 08:29 am
M&A
Pharmasset
Gilead
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
hepatitis C
Anadys
Roche
Gilead
Pharmasset
Bristol-Myers Squibb
Inhibitex
A White Hot Hep C Market: What The Wags Say
Pharmalot
Mon, 01/9/12 - 01:24 pm
hepatitis C
Inhibitex
Bristol-Myers Squibb
Gilead
Pharmasset
M&A
2 ETFs To Play A Surge In Biotech/Pharma M&A
Seeking Alpha
Mon, 01/9/12 - 10:39 am
Abbott Laboratories
Amgen
Biogen Idec
Gilead
Celgene
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
ETFs

Pages